tert-Butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate

Catalog No. :
ACABGC183
CAS No. :
1699971-24-8
Molecular Formula :
C15H23N3O4
Molecular Weight :
309.37

IUPAC Name:tert-butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate

tert-Butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$71.00Login to see priceInquiryInquiry
1g97%$156.00Login to see priceInquiryInquiry
5g97%$496.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate
IUPAC Nametert-butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate
Molecular FormulaC15H23N3O4
Molecular Weight309.37
SMILESO=C(OC(C)(C)C)NCCCNC1=CC=C(C)C=C1[N+]([O-])=O
InChI KeyQCRVVXPPOKMTBT-UHFFFAOYSA-N
Synonymtert-Butyl (3-((4-methyl-2-nitrophenyl)amino)propyl)carbamate;Carbamic acid, N-[3-[(4-methyl-2-nitrophenyl)amino]propyl]-, 1,1-dimethylethyl ester
CAS No.1699971-24-8
PubChem CID103684652

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACABGC183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCXDO403 route compound structure diagram
    ACCXDO403127346-48-9 In Stock
  2. Plus
  3. ACOMRX630 route compound structure diagram
    ACOMRX630446-11-7 In Stock
  4. Then
  5. ACABGC183 route product structure diagram
    ACABGC1831699971-24-8
Inquiry

2. ACABGC183 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACCXDO403 route compound structure diagram
    ACCXDO403127346-48-9 In Stock
  2. Plus
  3. ACQKIC649 route compound structure diagram
    ACQKIC64989-60-1 In Stock
  4. Then
  5. ACABGC183 route product structure diagram
    ACABGC1831699971-24-8
Inquiry

Comments (0)